Lincoln H. Wilkins, Ph.D. - Publications

Area:
Drug and alcohol abuse

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2006 Wilkins LH, Prendergast MA, Blanchard J, Holley RC, Chambers ER, Littleton JM. Potential value of changes in cell markers in organotypic hippocampal cultures associated with chronic EtOH exposure and withdrawal: comparison with NMDA-induced changes. Alcoholism, Clinical and Experimental Research. 30: 1768-80. PMID 17010144 DOI: 10.1111/j.1530-0277.2006.00210.x  0.64
2005 Wilkins LH, Miller DK, Ayers JT, Crooks PA, Dwoskin LP. N-n-alkylnicotinium analogs, a novel class of antagonists at alpha 4 beta 2* nicotinic acetylcholine receptors: inhibition of S(-)-nicotine-evoked 86Rb+ efflux from rat thalamic synaptosomes. The Aaps Journal. 7: E922-30. PMID 16594645 DOI: 10.1208/aapsj070490  0.64
2005 Sumithran SP, Crooks PA, Xu R, Zhu J, Deaciuc AG, Wilkins LH, Dwoskin LP. Introduction of unsaturation into the N-n-alkyl chain of the nicotinic receptor antagonists, NONI and NDNI: effect on affinity and selectivity. The Aaps Journal. 7: E201-17. PMID 16146341 DOI: 10.1208/aapsj070119  0.64
2004 Crews FT, Collins MA, Dlugos C, Littleton J, Wilkins L, Neafsey EJ, Pentney R, Snell LD, Tabakoff B, Zou J, Noronha A. Alcohol-induced neurodegeneration: when, where and why? Alcoholism, Clinical and Experimental Research. 28: 350-64. PMID 15112943 DOI: 10.1097/01.ALC.0000113416.65546.01  0.64
2004 Kute TE, Russell GB, Zbieranski N, Long R, Johnston S, Williams H, Stackhouse C, Wilkins L, Evans I, Berry P, Rimmer K, Tucker E. Prognostic markers in node-negative breast cancer: a prospective study. Cytometry. Part B, Clinical Cytometry. 59: 24-31. PMID 15108167 DOI: 10.1002/cyto.b.20003  0.64
2004 Crooks PA, Ayers JT, Xu R, Sumithran SP, Grinevich VP, Wilkins LH, Deaciuc AG, Allen DD, Dwoskin LP. Development of subtype-selective ligands as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release. Bioorganic & Medicinal Chemistry Letters. 14: 1869-74. PMID 15050618 DOI: 10.1016/j.bmcl.2003.10.074  0.64
2003 Mulholland PJ, Harris BR, Wilkins LH, Self RL, Blanchard JA, Holley RC, Littleton JM, Prendergast MA. Opposing effects of ethanol and nicotine on hippocampal calbindin-D28k expression. Alcohol (Fayetteville, N.Y.). 31: 1-10. PMID 14615005 DOI: 10.1016/j.alcohol.2003.09.001  0.64
2003 Wilkins LH, Grinevich VP, Ayers JT, Crooks PA, Dwoskin LP. N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with alpha4beta2* and alpha7* neuronal nicotinic receptors. The Journal of Pharmacology and Experimental Therapeutics. 304: 400-10. PMID 12490617 DOI: 10.1124/jpet.102.043349  0.64
2003 Gentry CL, Wilkins LH, Lukas RJ. Effects of prolonged nicotinic ligand exposure on function of heterologously expressed, human alpha4beta2- and alpha4beta4-nicotinic acetylcholine receptors. The Journal of Pharmacology and Experimental Therapeutics. 304: 206-16. PMID 12490593 DOI: 10.1124/jpet.102.041756  0.64
2002 Prendergast MA, Rogers DT, Mulholland PJ, Littleton JM, Wilkins LH, Self RL, Nath A. Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitive-site on the N-methyl-D-aspartate receptor. Brain Research. 954: 300-7. PMID 12414113 DOI: 10.1016/S0006-8993(02)03360-7  0.64
2002 Wilkins LH, Haubner A, Ayers JT, Crooks PA, Dwoskin LP. N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonist: inhibition of S(-)-nicotine-evoked [(3)H]dopamine overflow from superfused rat striatal slices. The Journal of Pharmacology and Experimental Therapeutics. 301: 1088-96. PMID 12023541 DOI: 10.1124/jpet.301.3.1088  0.64
2001 Miller DK, Wilkins LH, Bardo MT, Crooks PA, Dwoskin LP. Once weekly administration of nicotine produces long-lasting locomotor sensitization in rats via a nicotinic receptor-mediated mechanism. Psychopharmacology. 156: 469-76. PMID 11498725 DOI: 10.1007/s002130100747  0.64
2001 Butt CM, Pauly JR, Wilkins LH, Dwoskin LP, Debski EA. Pharmacology, distribution and development of muscarinic acetylcholine receptor subtypes in the optic tectum of Rana pipiens. Neuroscience. 104: 161-79. PMID 11311540 DOI: 10.1016/S0306-4522(01)00048-3  0.64
1999 Dwoskin LP, Wilkins LH, Pauly JR, Crooks PA. Development of a novel class of subtype-selective nicotinic receptor antagonist: pyridine-N-substituted nicotine analogs. Annals of the New York Academy of Sciences. 868: 617-9. PMID 10414342 DOI: 10.1111/j.1749-6632.1999.tb11334.x  0.64
1996 Collins AC, Wilkins LH, Slobe BS, Cao JZ, Bullock AE. Long-term ethanol and nicotine treatment elicit tolerance to ethanol. Alcoholism, Clinical and Experimental Research. 20: 990-9. PMID 8892517  0.64
1995 Crooks PA, Ravard A, Wilkins LH, Teng LH, Buxton ST, Dwoskin LP. Inhibition of nicotine-evoked [3H]dopamine release by pyridino N-substituted nicotine analogues: A new class of nicotinic antagonist Drug Development Research. 36: 91-102. DOI: 10.1002/ddr.430360204  0.64
1993 Cao W, Burkholder T, Wilkins L, Collins AC. A genetic comparison of behavioral actions of ethanol and nicotine in the mirrored chamber. Pharmacology, Biochemistry, and Behavior. 45: 803-9. PMID 8415818 DOI: 10.1016/0091-3057(93)90124-C  0.64
Show low-probability matches.